Vivos Therapeutics, Inc. Deferred Tax Assets, Deferred Gain on Sale Leaseback Transaction
Vivos Therapeutics, Inc. (VVOS) had Deferred Tax Assets, Deferred Gain on Sale Leaseback Transaction of $352.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction · last filed 2025-03-31
- 2024-12-31: Deferred Tax Assets, Deferred Gain on Sale Leaseback Transaction $352.00K.
- 2023-12-31: Deferred Tax Assets, Deferred Gain on Sale Leaseback Transaction $472.00K.
- 2022-12-31: Deferred Tax Assets, Deferred Gain on Sale Leaseback Transaction $561.00K.
| Period end | Deferred Tax Assets, Deferred Gain on Sale Leaseback Transaction |
|---|---|
| 2024-12-31 | $352.00K 10-K · filed 2025-03-31 |
| 2023-12-31 | $472.00K 10-K · filed 2025-03-31 |
| 2022-12-31 | $561.00K 10-K/A · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |